BSG Series CM, LLC Acquires 80.73% Stake in Z Squared Inc. via Merger Consideration

On May 4, 2026, BSG Series CM, LLC filed a Schedule 13D reporting an 80.73% ownership stake in Z Squared Inc. (formerly Coeptis Therapeutics Holdings, Inc.). The reporting person acquired 41,521,276 shares of Common Stock as merger consideration following the completion of a merger between the Issuer's subsidiary and Z Squared Opco, Inc. on April 24, 2026. No cash was used for the acquisition, as the shares were received in exchange for pre-merger holdings in OpCo. BSG Series CM, LLC intends to eventually distribute these shares pro rata to its members. The shares are subject to significant lock-up and leak-out provisions, which generally restrict sales unless the stock price exceeds $16.31 per share or $35.00 under specific conditions. Additionally, for 18 months following the Nasdaq listing on April 27, 2026, the filer is limited to selling no more than one-eighteenth of its holdings per month, subject to volume limitations and a prohibition on short selling.